Clearside Biomedical names chief medical officer
Dr. Beckman is a board certified ophthalmologist who brings 13 years of clinical practice experience and over 20 years of corporate executive and consultancy experience within the global ophthalmic industry to Clearside.
Prior to joining Clearside, Dr. Beckman managed a successful pharmaceutical and medical device industry consulting firm that served a broad range of companies.
Previously, he held the position of Chief Medical Officer and General Manager of the Ocular and Novel Drug Delivery Systems business unit at Unilife Corporation.
Dr. Beckman also held various leadership roles with Ophthotech Pharmaceuticals, Danube Pharmaceuticals, Becton-Dickinson, Neurotech Pharmaceuticals, Alcon Laboratories, Lux Pharmaceuticals and Allergan.
Dr. Beckman received his medical degree from the University of Michigan, and practiced as a glaucoma specialist for ten years in private practice and three years in academic practice at North Shore University Hospital-Cornell University Medical College, following an ophthalmology residency at Henry Ford Hospital and a Glaucoma Fellowship at Harvard University. ■
LATEST MOVES FROM Georgia
- Georgia Power appoints Mark Burns to board
- Asbury Automotive Group confirms Sean D. Goodman as new SVP, CFO
- State Bank Financial names J. Thomas Wiley as CEO
- Fleetcor Technologies appoints Hala Moddelmog to board
- AdCare Health terminates CEO for misrepresenting educational credentials
More inside POST
Alphabet Q1 revenue $24.8 billion Earnings